Articles From: BioAmber Announces Webcast of Fiscal Second Quarter 2014 Financial Results to BioCryst to Present Peramivir Trial Results for the Treatment of Influenza at the ICAAC 2014 Meeting


MINNEAPOLIS, MN , July 18, 2014 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA) , an industrial biotechnology company producing renewable chemicals, announced today that it will report its financial results for the second quarter 2014 on Thursday August 7, 2014 .
Sign-up for BioAmber Announces Webcast of Fiscal Second Quarter 2014 Financial Results investment picks
BioAmber Inc. announces pricing of $33.6 million registered offering Canada NewsWire MINNEAPOLIS, MN , July 16, 2014 /CNW/ - BioAmber Inc. (NYSE: BIOA) , an industrial biotechnology company producing sustainable chemicals, today announced that it has priced an underwritten registered offering of 2,800,000 shares of its common stock at a price of $12.00 per share, and granted the underwriters in the offering a 30-day option to purchase up to an additional 420,000 shares of its common stock.
Sign-up for BioAmber Inc. announces pricing of $33.6 million registered offering investment picks
MINNEAPOLIS, MN , July 16, 2014 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA) , an industrial biotechnology company producing sustainable chemicals, today announced that it has priced an underwritten registered offering of 2,800,000 shares of its common stock at a price of $12.00 per share, and granted the underwriters in the offering a 30-day option to purchase up to an additional 420,000 shares of its common stock.
Sign-up for BioAmber Inc. announces pricing of $33.6 million registered offering investment picks
BioAmber Inc. announces public offering of common stock Canada NewsWire MINNEAPOLIS, MN , July 15, 2014 /CNW Telbec/ - BioAmber Inc. (NYSE: BIOA) , an industrial biotechnology company producing sustainable chemicals, today announced that it has commenced a public offering of 2,800,000 shares of its common stock.
Sign-up for BioAmber Inc. announces public offering of common stock investment picks
MINNEAPOLIS, MN , July 15, 2014 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA) , an industrial biotechnology company producing sustainable chemicals, today announced that it has commenced a public offering of 2,800,000 shares of its common stock.
Sign-up for BioAmber Inc. announces public offering of common stock investment picks
MINNEAPOLIS, MN , Aug.
Sign-up for BioAmber Reports Second Quarter 2014 Financial Results investment picks
BioAmber Signs Exclusive Supply Agreement for Bio-Succinic Acid Canada NewsWire 5 year supply agreement is with Xuchuan Chemical, a global leader in polyester polyols BioAmber bio-succinic acid will initially be used to produce cast polyurethane elastomers (CPU). Other applications for BioAmber succinic acid include resins for shoe soles and synthetic leathers Xuchuan operates 4 production facilities in China , with a total capacity of 150,000 tons per year The market opportunity for bio-succinic acid at Xuchuan is several thousand tons per year MONTREAL , Oct.
Sign-up for BioAmber Signs Exclusive Supply Agreement for Bio-Succinic Acid investment picks
5 year supply agreement is with Xuchuan Chemical, a global leader in polyester polyols BioAmber bio-succinic acid will initially be used to produce cast polyurethane elastomers (CPU). Other applications for BioAmber succinic acid include resins for shoe soles and synthetic leathers Xuchuan operates 4 production facilities in China , with a total capacity of 150,000 tons per year The market opportunity for bio-succinic acid at Xuchuan is several thousand tons per year MONTREAL , Oct.
Sign-up for BioAmber Signs Exclusive Supply Agreement for Bio-Succinic Acid investment picks
Interim Data on First 11 Patients in the Ongoing Phase 2/3 HOPEMD Study Suggest Cabaletta to be Safe and Well Tolerated with No Drug Related Adverse Events TEL AVIV, Israel, Sept.
Sign-up for BioBlast Pharma Announces Preclinical and Clinical Pharmacokinetic Results With Cabaletta, Interim Safety Results From Phase 2/3 HOPEMD Study in OPMD investment picks
TEL AVIV, Israel, Aug.
Sign-up for BioBlast Pharma Reports Second Quarter Financial Results investment picks
TEL AVIV, Israel, Sept.
Sign-up for BioBlast to Ring the NASDAQ Stock Market Opening Bell investment picks
SAN DIEGO, Oct.
Sign-up for Biocept Expands Collaboration With MD Anderson Cancer Center investment picks
SAN DIEGO, Aug.
Sign-up for Biocept Provides Second Quarter Operational Update investment picks
SAN DIEGO, Sept.
Sign-up for Biocept Strengthens Its Circulating Tumor Cell IP Position in Europe investment picks
SAN DIEGO, Sept.
Sign-up for Biocept to Present at the 13th Annual BIO Investor Forum investment picks
SAN DIEGO, Sept.
Sign-up for Biocept to Present at Upcoming Investor Conferences investment picks
RESEARCH TRIANGLE PARK, N.C., Oct.
Sign-up for BioCryst Announces Late Breaker Presentation of OPuS-1 Phase 2 Trial Results at the 23rd EADV Congress investment picks
RESEARCH TRIANGLE PARK, N.C., Sept.
Sign-up for BioCryst Announces RAPIVAB(TM) Trial Results for the Treatment of Influenza at the ICAAC 2014 Meeting investment picks
RESEARCH TRIANGLE PARK, N.C., Sept.
Sign-up for BioCryst Participates in World Health Organization Consultation on Potential Ebola Therapies investment picks
RESEARCH TRIANGLE PARK, N.C., Sept.
Sign-up for BioCryst Receives Additional NIAID Funding for Manufacture and Development of BCX4430 to Treat Hemorrhagic Virus Diseases investment picks
RESEARCH TRIANGLE PARK, N.C., Aug.
Sign-up for BioCryst Receives Additional NIAID Funding to Advance Development of BCX4430 to Treat Hemorrhagic Fever Virus Diseases investment picks
RESEARCH TRIANGLE PARK, N.C., Aug.
Sign-up for BioCryst Receives Additional NIAID Funding to Conduct a Non-Human Primate Study of BCX4430 in Ebola Virus Disease investment picks
RESEARCH TRIANGLE PARK, N.C., Aug.
Sign-up for BioCryst Reports Second Quarter 2014 Financial Results investment picks
RESEARCH TRIANGLE PARK, N.C., July 22, 2014 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that its second quarter 2014 financial results will be released on Tuesday, August 5, 2014.
Sign-up for BioCryst to Announce Second Quarter 2014 Financial Results August 5 investment picks
RESEARCH TRIANGLE PARK, N.C., Sept.
Sign-up for BioCryst to Present at Rodman & Renshaw Conference investment picks
RESEARCH TRIANGLE PARK, N.C., Sept.
Sign-up for BioCryst to Present Peramivir Trial Results for the Treatment of Influenza at the ICAAC 2014 Meeting investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: BioAmber Announces Webcast of Fiscal Second Quarter 2014 Financial Results to BioCryst to Present Peramivir Trial Results for the Treatment of Influenza at the ICAAC 2014 Meeting
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices